Explanatory Notes

Page last updated: 12 February 2020

Front Matter

Section 4 – Extemporaneously-Prepared Pharmaceutical Benefits

This collection of explanatory notes contains information on:

Price Premium Explanatory Notes

This collection of explanatory notes contains information on:

Efficient Funding of Chemotherapy – Section 100 Arrangements